Clinical Trials Browser

Phase 2 × eltrombopag × Classical hematology × Clear all

NCT04600960 2025-02-24

Eltrombopag for Chemotherapy-induced Thrombocytopenia

Phase 2 Recruiting

Classical hematology

Chemotherapy-induced Thrombocytopenia

NCT01168921 2023-03-23

Phase II Eltrombopag in Chronic Lymphocytic Leukemia (CLL)

Phase 2 Completed

23 enrolled 9 charts

Classical hematologyLymphoidOther hematologic neoplasm

Jacobs syndrome, Leukemia, Thrombocytopenia, Leukemia, Lymphocytic, Chronic, B-Cell

NCT01890746 2019-09-11

A Safety and Efficacy Study of Eltrombopag in Subjects With AML

Phase 2 Completed

148 enrolled 42 charts

Classical hematologyOther hematologic neoplasm

Leukemia, Thrombocytopenia, Leukemia, Myeloid, Acute

NCT01440374 2017-06-05

ASPIRE

Phase 2 Completed

162 enrolled 24 charts

Classical hematologyMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Myeloproliferative Disorders, Thrombocytopenia, Leukemia, Myeloid, Acute

NCT00102726 2017-03-23

SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving Chemotherapy

Phase 2 Completed

Classical hematology

Jacobs syndrome, Thrombocytopenia

NCT01484314 2017-03-15

Eltrombopag for Thrombocytopenia in Patients With Relapsed Multiple Myeloma

Phase 2 Terminated

1 enrolled 1 chart

Classical hematologyPlasma cell

Multiple Myeloma, Recurrence, Thrombocytopenia

NCT01500538 2016-02-15

VEIL

Phase 2 Terminated

Classical hematologyLymphoid

Lymphoma, Lymphoma, Follicular, Thrombocytopenia, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell